Crystal structure from X-ray powder diffraction data, DFT-D calculation, Hirshfeld surface analysis, and energy frameworks of ()-trichlorme-thia-zide.

The structure of racemic ()-trichlorme-thia-zide [systematic name: ()-6-chloro-3-(di-chloro-meth-yl)-1,1-dioxo-3,4-di-hydro-2-1λ,2,4-benzo-thia-di-azine-7-sulfonamide], CHClNOS (-TCMZ), a diuretic drug used in the treatment of oedema and hypertension, was determined from laboratory X-ray powder diffraction data using [David (2006 ▸). , 910-915.], refined by the Rietveld method with [Coelho (2018 ▸). , 210-218], and optimized using DFT-D calculations. The extended structure consists of head-to-tail dimers connected by π-π inter-actions which, in turn, are connected by C-Cl⋯π inter-actions. They form chains propagating along [101], further connected by N-H⋯O hydrogen bonds to produce layers parallel to the plane that stack along the -axis direction, connected by additional N-H⋯O hydrogen bonds. The Hirshfeld surface analysis indicates a major contribution of H⋯O and H⋯Cl inter-actions (32.2 and 21.7%, respectively). Energy framework calculations confirm the major contribution of electrostatic inter-actions ( ) to the total energy ( ). A comparison with the structure of -TCMZ is also presented.